Peginterferon α-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response
Kamal, S M, El Tawil, A A, Nakano, T, He, Q, Rasenack, J, Hakam, S A, Saleh, W A, Ismail, A, Aziz, A A, Madwar, M Ali
Published in Gut (01.06.2005)
Published in Gut (01.06.2005)
Get full text
Journal Article
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial
Buti, M., Flisiak, R., Kao, J.-H., Chuang, W.-L., Streinu-Cercel, A., Tabak, F., Calistru, P., Goeser, T., Rasenack, J., Horban, A., Davis, G. L., Alberti, A., Mazzella, G., Pol, S., Orsenigo, R., Brass, C.
Published in Journal of viral hepatitis (01.07.2015)
Published in Journal of viral hepatitis (01.07.2015)
Get full text
Journal Article
P747 ASSOCIATION OF A GENETIC VARIANT OF THE MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN (MAVS) WITH INTERFERON RESPONSE IN CHRONIC HEPATITIS C VIRUS INFECTION
Fischer, J, Böhm, S, Deichsel, D, Knop, V, Klinker, H, Möller, B, Rasenack, J, Hinrichsen, H, Spengler, U, Buggisch, P, Sarrazin, C, Berg, T
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
1421 ALISPORIVIR (ALV) PLUS PEGINTERFERON/RIBAVIRIN (PR) ACHIEVES HIGH SVR12 RATES AMONG NULL RESPONDERS, IL28BCT/TT AND CIRRHOTIC HCVG1 PATIENTS (FUNDAMENTAL STUDY INTERIM ANALYSIS)
Buti, M, Flisiak, R, Rasenack, J, Davis, G, Alberti, A, Goeser, T, Stanciu, C, Chuang, W.-L, Tabak, F, Kao, J.-H, Streinu-Cercel, A, Hofstetter, G, Wang, J, Avila, C, Orsenigo, R
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
9 ASSOCIATION OF A GENETIC VARIANT OF THE TOLL-LIKE RECEPTOR 9 (TLR9) WITH SPONTANEOUS VIRAL CLEARANCE AND WITH INTERFERON RESPONSE IN CHRONIC HEPATITIS C VIRUS INFECTION
Fischer, J, Böhm, S, Deichsel, D, Knop, V, Klinker, H, Möller, B, Rasenack, J, Hinrichsen, H, Spengler, U, Buggisch, P, Sarrazin, C, Berg, T
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
745 eGFR IMPROVEMENT IN CHRONIC HEPATITIS B PATIENTS WITH TELBIVUDINE TREATMENT IS INDEPENDENT OF ANTIVIRAL ACTIVITY
Gane, E.J, Liaw, Y.F, Wang, Y, Lai, C.-L, Rasenack, J, Zeuzem, S, Chan, H.L.Y, Ren, H, Dong, Y, Uddin, A, Jung, M.E, Bosset, S, Trylesinski, A
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
Re-treatment of chronic hepatitis C patients after relapse: efficacy of peginterferon-alpha-2a (40 kDa) and ribavirin
Berg, C., Goncales Jr, F. L., Bernstein, D. E., Sette Jr, H., Rasenack, J., Diago, M., Jensen, D. M., Graham, P., Cooksley, G.
Published in Journal of viral hepatitis (01.07.2006)
Published in Journal of viral hepatitis (01.07.2006)
Get full text
Journal Article
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
Foster, G. R., Zeuzem, S., Pianko, S., Sarin, S. K., Piratvisuth, T., Shah, S., Andreone, P., Sood, A., Chuang, W.-L., Lee, C.-M., George, J., Gould, M., Flisiak, R., Jacobson, I. M., Komolmit, P., Thongsawat, S., Tanwandee, T., Rasenack, J., Sola, R., Messina, I., Yin, Y., Cammarata, S., Feutren, G., Brown, K. K.
Published in Journal of viral hepatitis (01.04.2013)
Published in Journal of viral hepatitis (01.04.2013)
Get full text
Journal Article
Prefrontal cortical hypometabolism during low-dose interferon alpha treatment
JUENGLING, Freimut D, EBERT, Dieter, GUT, Oliver, ENGELBRECHT, Marc A, RASENACK, J, NITZSCHE, Egbert U, BAUER, Joachim, LIEB, Klaus
Published in Psychopharmacologia (01.11.2000)
Published in Psychopharmacologia (01.11.2000)
Get full text
Journal Article
1405 ALISPORIVIR PLUS RIBAVIRIN IS HIGHLY EFFECTIVE AS INTERFERON-FREE OR INTERFERON-ADD-ON REGIMEN IN PREVIOUSLY UNTREATED HCV-GT2 OR GT3 PATIENTS: SVR12 RESULTS FROM VITAL-1 PHASE 2B STUDY
Pawlotsky, J.-M, Sarin, S.K, Foster, G, Peng, C.-Y, Rasenack, J, Flisiak, R, Piratvisuth, T, Wedemeyer, H, Chuang, W.-L, Zhang, W.M, Naoumov, N.V
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3
Pianko, S., Zeuzem, S., Chuang, W.-L., Foster, G. R., Sarin, S. K., Flisiak, R., Lee, C.-M., Andreone, P., Piratvisuth, T., Shah, S., Sood, A., George, J., Gould, M., Komolmit, P., Thongsawat, S., Tanwandee, T., Rasenack, J., Li, Y., Pang, M., Yin, Y., Feutren, G., Jacobson, I. M.
Published in Journal of viral hepatitis (01.09.2012)
Published in Journal of viral hepatitis (01.09.2012)
Get full text
Journal Article
Veno-Occlusive Disease in a Fetus Caused by Pyrrolizidine Alkaloids of Food Origin
Rasenack, R., Müller, C., Kleinschmidt, M., Rasenack, J., Wiedenfeld, H.
Published in Fetal diagnosis and therapy (01.07.2003)
Published in Fetal diagnosis and therapy (01.07.2003)
Get full text
Journal Article
424 RESPIRATORY ALTERATIONS IN GENOTYPE 2/3 CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON OR ALBINTERFERON-ALFA-2B PLUS RIBAVIRIN IN A RANDOMIZED STUDY
Foster, G, Flisiak, R, Chuang, W.-L, George, J, Rasenack, J, Sood, A, Komolmit, P, Thongsawat, S, Tanwandee, T, Sola, R, Sukeepaisarnjaroen, W, Weltman, M, Yin, Y, Feutren, G, Brown, K
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
1351 PREDICTION OF RELAPSE AFTER PEGINTERFERON ALFA-2B/RIBAVIRIN THERAPY IN CHRONIC HCV GENOTYPE 1 PATIENTS IS DEPENDENT ON MINIMAL RESIDUAL VIREMIA BUT NOT ON IL28B GENOTYPE
Wiegand, J, Neumann, K, Böhm, S, Weich, V, Klinker, H, Möller, B, Rasenack, J, Hinrichsen, H, Gerlach, T, Spengler, U, Buggisch, P, Sarrazin, C, Berg, T
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response
Kamal, S M, Rasenack, J W, Bianchi, L, Al Tawil, A, El Sayed Khalifa, K, Peter, T, Mansour, H, Ezzat, W, Koziel, M
Published in Gastroenterology (New York, N.Y. 1943) (01.09.2001)
Published in Gastroenterology (New York, N.Y. 1943) (01.09.2001)
Get more information
Journal Article
Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn’s disease
Gross, V, Andus, T, Ecker, K W, Raedler, A, Loeschke, K, Plauth, M, Rasenack, J, Weber, A, Gierend, M, Ewe, K, Schölmerich, J
Published in Gut (01.04.1998)
Published in Gut (01.04.1998)
Get full text
Journal Article